Clinical trial
Effectiveness of Stromal Vascular Fraction (SVF) and Platelet -Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Study Protocol for a Phase III, Prospective, Randomized, Controlled Multi-center Study : (SPOST Study)
NCT05660824 is registered in ClinicalTrials.gov with Adrien Schwitzguebel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Stromal Vascular Fraction (SVF) and Platelet -Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Study Protocol for a Phase III, Prospective, Randomized, Controlled Multi-center Study : (SPOST Study)
- Lead sponsor
- Adrien Schwitzguebel
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- July 31, 2025
- Completion date
- August 31, 2027
- Enrollment
- 108 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.